Literature DB >> 3501518

Long-term culture of murine bone marrow precursors of B lymphocytes.

C A Whitlock, O N Witte.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3501518     DOI： 10.1016/0076-6879(87)50085-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  22 in total

1.  INK4d-deficient mice are fertile despite testicular atrophy.

Authors:  F Zindy; J van Deursen; G Grosveld; C J Sherr; M F Roussel
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Early B lymphocyte development: Similarities and differences in human and mouse.

Authors:  Michiko Ichii; Kenji Oritani; Yuzuru Kanakura
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

3.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

4.  PIAS1 Promotes Lymphomagenesis through MYC Upregulation.

Authors:  Andrea Rabellino; Margherita Melegari; Van S Tompkins; Weina Chen; Brian G Van Ness; Julie Teruya-Feldstein; Maralice Conacci-Sorrell; Siegfried Janz; Pier Paolo Scaglioni
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

5.  High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.

Authors:  Janet Bijl; Martin Sauvageau; Alexander Thompson; Guy Sauvageau
Journal:  Genes Dev       Date:  2005-01-15       Impact factor: 11.361

6.  Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.

Authors:  Michelle L Churchman; Maoxiang Qian; Geertruy Te Kronnie; Ranran Zhang; Wenjian Yang; Hui Zhang; Tobia Lana; Paige Tedrick; Rebekah Baskin; Katherine Verbist; Jennifer L Peters; Meenakshi Devidas; Eric Larsen; Ian M Moore; Zhaohui Gu; Chunxu Qu; Hiroki Yoshihara; Shaina N Porter; Shondra M Pruett-Miller; Gang Wu; Elizabeth Raetz; Paul L Martin; W Paul Bowman; Naomi Winick; Elaine Mardis; Robert Fulton; Martin Stanulla; William E Evans; Mary V Relling; Ching-Hon Pui; Stephen P Hunger; Mignon L Loh; Rupert Handgretinger; Kim E Nichols; Jun J Yang; Charles G Mullighan
Journal:  Cancer Cell       Date:  2018-04-19       Impact factor: 31.743

7.  Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.

Authors:  Richard T Williams; Willem den Besten; Charles J Sherr
Journal:  Genes Dev       Date:  2007-08-30       Impact factor: 11.361

8.  Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.

Authors:  G V Borzillo; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

9.  Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL.

Authors:  Iris Appelmann; Cory D Rillahan; Elisa de Stanchina; Gregory Carbonetti; Chong Chen; Scott W Lowe; Charles J Sherr
Journal:  Blood       Date:  2014-12-12       Impact factor: 22.113

10.  Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL.

Authors:  Michelle L Churchman; Kathryn Evans; Jennifer Richmond; Alissa Robbins; Luke Jones; Irina M Shapiro; Jonathan A Pachter; David T Weaver; Peter J Houghton; Malcolm A Smith; Richard B Lock; Charles G Mullighan
Journal:  JCI Insight       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.